• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More or Call (407) 374-6986

Saturday 12/15/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

LuViva

  • 3:36 PM

    Jun 07, 2016, GTHP OTC Disclosure & News Service – Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has reached a licensing agreement with Shenghuo Medical, LLC, for exclusive sales and manufacturing rights of the LuViva® Advanced Cervical Scan for China and several additional Southeast Asian countries. Shenghuo brought Chinese investors into GTHP last year and currently owns the distribution rights to China. The

    Read more
  • 3:10 PM

    Jan 12, 2016, GTHP OTC Disclosure & News Service – Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today fourth quarter sales revenue for the LuViva® Advanced Cervical Scan was the highest since the launch of the product. LuViva product revenue was approximately $276,000 for the fourth quarter of 2015 versus approximately $183,000 for the same period of 2014, an increase of about 51%. Total sales for

    Read more
  • 2:21 PM

    Nov 05, 2015 OTC Disclosure & News Service, OTCQB, ENCR – Ener-Core, Inc. (“Ener-Core”) (OTCQB:ENCR), a provider of commercialized Power Oxidation technology and equipment that generates clean power from low-quality waste gases and is deployable in a wide variety of industries, today announced the launch of an underwritten public offering of 2,250,000 units, subject to market and other conditions, pursuant to a registration statement on Form S-1 filed with the Securities and Exchange Commission (“SEC”). Each unit consists of a

    Read more
  • 5:37 PM

    Jun 26, 2015 OTC Disclosure & News Service -Sangui Biotech International, Inc. has filed a preliminary S-1 Registration Statement with the Securities and Exchange Commission. It is being expected that the SEC will declare the Prospectus effective within the next couple of weeks. The exact timeline depends on SEC approval procedures which cannot be anticipated by the company. The S-1 becoming effective is prerequisite for Sangui to start drawing upon the financial framework agreement with US investor Southridge as announced

    Read more
  • 4:35 PM

    http://www.publicwire.com SAN DIEGO, Calif., April 2, 2014 /PRNewswire via COMTEX/ — Mind Solutions, Inc. (OTCQB – VOIS), announces the receipt of a $1,000,000 funding commitment that will enable the Company to initiate its business model and further the development of their proprietary EEG/ BCI mobile headset. The funding commitment provided requires the Company to file an S-1 Registration Statement with the Securities Exchange Commission to become “Effective” prior to receiving funds. From there, the Company may draw down monthly tranches

    Read more
Public Wire Banner